HF imposes a staggering economic burden on the healthcare system, with most of the
costs for the care of patients with HF attributable to hospitalizations.
1
More than 1 million hospitalizations for HF occur in the United States annually.
2
Also, HF has the greatest 30-day rehospitalization rate of any diagnosis among Medicare
beneficiaries.
- Roger V.L.
- Go A.S.
- Lloyd-Jones D.M.
- Benjamin E.J.
- Berry J.D.
- Borden W.B.
- Bravata D.M.
- Dai S.
- Ford E.S.
- Fox C.S.
- Fullerton H.J.
- Gillespie C.
- Hailpern S.M.
- Heit J.A.
- Howard V.J.
- Kissela B.M.
- Kittner S.J.
- Lackland D.T.
- Lichtman J.H.
- Lisabeth L.D.
- Makuc D.M.
- Marcus G.M.
- Marelli A.
- Matchar D.B.
- Moy C.S.
- Mozaffarian D.
- Mussolino M.E.
- Nichol G.
- Paynter N.P.
- Soliman E.Z.
- Sorlie P.D.
- Sotoodehnia N.
- Turan T.N.
- Virani S.S.
- Wong N.D.
- Woo D.
- Turner M.B.
Heart disease and stroke statistics–2012 update: a report from the American Heart
Association.
Circulation. 2012; 125: e2-e220
3
Accordingly, the initial and subsequent hospitalizations among patients with HF constitute
a major public health problem and have been a recent focus in the healthcare reform
debate.To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to American Journal of CardiologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Lifetime costs of medical care after heart failure diagnosis.Circ Cardiovasc Qual Outcomes. 2011; 4: 68-75
- Heart disease and stroke statistics–2012 update: a report from the American Heart Association.Circulation. 2012; 125: e2-e220
- Rehospitalizations among patients in the Medicare fee-for-service program.N Engl J Med. 2009; 360: 1418-1428
- Thirty-day readmissions—truth and consequences.N Engl J Med. 2012; 366: 1366-1369
- Statistical models and patient predictors of readmission for heart failure: a systematic review.Arch Intern Med. 2008; 168: 1371-1386
- Relationship between early physician follow-up and 30-day readmission among Medicare beneficiaries hospitalized for heart failure.JAMA. 2010; 303: 1716-1722
- Effect of hospital follow-up appointment on clinical event outcomes and mortality.Arch Intern Med. 2010; 170: 955-960
- Hospitalizations after heart failure diagnosis a community perspective.J Am Coll Cardiol. 2009; 54: 1695-1702
- Hospitalizations in patients with heart failure: who and why.J Am Coll Cardiol. 2009; 54: 1703-1705
- Intrathoracic impedance monitoring in patients with heart failure: correlation with fluid status and feasibility of early warning preceding hospitalization.Circulation. 2005; 112: 841-848
- Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure.N Engl J Med. 2004; 350: 2140-2150
- ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons.J Am Coll Cardiol. 2008; 51: e1-e62
- Implementation of device therapy (cardiac resynchronization therapy and implantable cardioverter defibrillator) for patients with heart failure in Europe: changes from 2004 to 2008.Eur J Heart Fail. 2009; 11: 1143-1151
- Development of a method to risk stratify heart failure patients for 30 day readmission using implantable device diagnostics.Am J Cardiol. 2013; 111: 79-84
- Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure) study.J Am Coll Cardiol. 2010; 55: 1803-1810
- Changes in intrathoracic impedance are associated with subsequent risk of hospitalizations for acute decompensated heart failure: clinical utility of implanted device monitoring without a patient alert.J Card Fail. 2009; 15: 475-481
- Intrathoracic impedance vs daily weight monitoring for predicting worsening heart failure events: results of the Fluid Accumulation Status Trial (FAST).Congestive Heart Fail. 2011; 17: 51-55
- The CONNECT (Clinical Evaluation of Remote Notification to Reduce Time to Clinical Decision) trial: the value of wireless remote monitoring with automatic clinician alerts.J Am Coll Cardiol. 2011; 57: 1181-1189
- Insights from Internet-based remote intrathoracic impedance monitoring as part of a heart failure disease management program.Congestive Heart Fail. 2010; 16: 159-163
- Trends in prevalence and outcome of heart failure with preserved ejection fraction.N Engl J Med. 2006; 355: 251-259
- Recent national trends in readmission rates after heart failure hospitalization.Circ Heart Fail. 2010; 3: 97-103
- Telemonitoring in patients with heart failure.N Engl J Med. 2010; 363: 2301-2309
- Contemporary evidence about hospital strategies for reducing 30-day readmissions: a national study.J Am Coll Cardiol. 2012; 60: 607-614
Article Info
Publication History
Published online: October 04, 2012
Identification
Copyright
© 2013 Elsevier Inc. Published by Elsevier Inc. All rights reserved.
ScienceDirect
Access this article on ScienceDirectLinked Article
- Development of a Method to Risk Stratify Patients With Heart Failure for 30-Day Readmission Using Implantable Device DiagnosticsAmerican Journal of CardiologyVol. 111Issue 1
- PreviewThe aim of the present study was to evaluate whether diagnostic data collected after a heart failure (HF) hospitalization can identify patients with HF at risk of early readmission. The diagnostic data from cardiac resynchronization therapy defibrillator (CRT-D) devices can identify outpatient HF patients at risk of future HF events. In the present retrospective analysis of 4 studies, we identified patients with CRT-D devices, with a HF admission, and 30-day postdischarge follow-up data. The evaluation of the diagnostic data for impedance, atrial fibrillation, ventricular heart rate during atrial fibrillation, loss of CRT-D pacing, night heart rate, and heart rate variability was modeled to simulate a review of the first 7 days after discharge on the seventh day.
- Full-Text
- Preview
